Exodus Point Capital Management, LP Emergent Bio Solutions Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$3.17 - $7.91 $34,698 - $86,582	10,946 New	10,946 $37,000
Q3 2022 Nov 10, 2022	SELL	$20.09 - $35.8 $673,999 - $1.2 Million	-33,549 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$27.42 - $43.63 $919,913 - $1.46 Million	33,549 New	33,549 $1.04 Million
Q1 2022 May 13, 2022	SELL	$36.48 - $52.22 $348,201 - $498,439	-9,545 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$33.11 - $55.01 $316,034 - $525,070	9,545 New	9,545 $415,000
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $377,878 - $435,803	-7,379 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $299,587 - $422,078	7,379 New	7,379 $386,000

172

36.8M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.